Azaindoles having serotonin receptor affinity
AssigneeNPS Allelix Corp.
InventorsLouise Edwards, Abdelmalik Slassi, Ashok Tehim, Tao Xin
Life of this patent
Estimating the term…
Loading patent…
AssigneeNPS Allelix Corp.
InventorsLouise Edwards, Abdelmalik Slassi, Ashok Tehim, Tao Xin
Estimating the term…
Described herein are compounds with affinity for the 5-HT6 receptor, which have the general formula I: wherein: R represents a group of Formula II or Formula III; one of A, B D or E is a N atom, the remainder being CH groups; R1 is selected from the group consisting of SO2Ar, C(O)Ar, CH2Ar and Ar; R2, R3 and R4 are independently selected from the group consisting of H and alkyl; represents a single or double bond, with the proviso that there is only one double bond in the ring at a time; n is an integer of from 1-3; Z is selected from the group consisting of C, CH and N, provided that when is a double bond, Z is C and when is a single bond, Z is selected from CH and N; Ar is an optionally substituted aryl group; with the proviso that when R is a group of Formula II, R1 is SO2Ar. Also described is the use of these compounds as pharmaceuticals to treat indications where inhibition of the 5-HT6 receptor is implicated, such as schizophrenia.
A compound according to Formula I and a salt, solvate or hydrate thereof, wherein:
A compound selected from the group consisting of:
Dependencies are inferred from the claim text.